Stay updated with breaking news from Threshold Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Initial Results From A Phase 1 Study of CFT8634, A Novel Bifunctional Degradation Activating Compound of BRD9, in Synovial Sarcoma and SMARCB1-Null Tumors ...
Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics...
Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive and entrepreneur, appointed Chief Executive Officer Carin Rollins, Hinge...
Hinge Bio Expands Senior Management Team to Drive GEM-DIMER™ Programs to Clinical Development - read this article along with other careers information, tips and advice on BioSpace
Jim Herbert to Take Leave of Absence; Mike Roffler Named President ... | December 13, 2021